Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.
Press releases published on May 27, 2025
Novel Viscoelastic Coagulation Monitor (VCM) Granted FDA Breakthrough Designation for Assessing Preterm Neonates
EIN Presswire
·
May 27, 2025
VCM to be Used to Assess Coagulation Status from Whole Blood of Preterm Neonates Aged 28 or More Weeks, Full Term and Newborns up to Six Months Post-Birth DURHAM, NC, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- Entegrion, Inc., a leading developer …
SONSIEL and The DAISY Foundation Celebrate Nurse Innovation at THInC with Inaugural DAISY Awards
EIN Presswire
·
May 27, 2025
BOSTON, MA, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- In a landmark moment for nursing innovation and recognition, the Society of Nurse Scientists, Innovators, Entrepreneurs, and Leaders (SONSIEL) and The DAISY Foundation proudly presented the …
Extendicare Announces Voting Results for its 2025 Annual and Special Meeting of Shareholders
GlobeNewswire
·
May 27, 2025
MARKHAM, Ontario, May 27, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual and special meeting of shareholders held on May 27, 2025 (the “Meeting”). The …
Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA
GlobeNewswire
·
May 27, 2025
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of celiac disease Candidate demonstrates Teva’s commitment to …
Teva to Present at Jefferies Global Healthcare Conference and Goldman Sachs Global Healthcare Conference in June
GlobeNewswire
·
May 27, 2025
TEL AVIV, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that members of its executive management team will present at two upcoming investor conferences in June as follows: Jefferies …
BioAge Labs to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 27, 2025
EMERYVILLE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging …
Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025
GlobeNewswire
·
May 27, 2025
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, will host an investor call and live webcast to review updated data from the global …
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
GlobeNewswire
·
May 27, 2025
BURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced an …
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
GlobeNewswire
·
May 27, 2025
SOUTH SAN FRANCISCO, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that Jason Okazaki, chief executive …
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
GlobeNewswire
·
May 27, 2025
SALT LAKE CITY, May 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share data from seven new research studies at the 2025 ASCO Annual Meeting, including …
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call
GlobeNewswire
·
May 27, 2025
DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the …
Inventiva Participera à la « Jefferies Global Healthcare Conference » et à la « UBS Spring Biotech Conference »
GlobeNewswire
·
May 27, 2025
Daix (France), New York City (New York, Etats-Unis), le 27 mai 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la …
Scientific Industries to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
GlobeNewswire
·
May 27, 2025
BOHEMIA, N.Y., May 27, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it will participate in a webcast presentation and host one- …
Pattern Computer Announces Hepatocellular Carcinoma Pattern Identification and Model Creation Study
GlobeNewswire
·
May 27, 2025
Study leveraged Pattern Discovery Engine™ to construct highly accurate model to predict whether or not a given cell is cancerous Identified nine genes that are crucial for prediction and may have other uses in diagnostics and/or therapeutics Highlights use …
CARBIOS unterzeichnet erste Verträge über den Verkauf von biologisch recyceltem PET mit zwei weltweit führenden Kosmetikunternehmen
GlobeNewswire
·
May 27, 2025
CARBIOS hat zwei mehrjährige Verträge mit L'ORÉAL und L'Occitane en Provence über den Verkauf von enzymatisch recyceltem und recycelbarem PET aus seiner Anlage in Longlaville unterzeichnet und hat die Umsetzung seiner Strategie für die künftige Anlage …
CARBIOS signs its first biorecycled PET sales contracts with two global cosmetics leaders
GlobeNewswire
·
May 27, 2025
CARBIOS has signed two multi-year commercial contracts for biorecycled PET from its Longlaville plant, with L'ORÉAL and L'Occitane en Provence, and has moved forward with the execution of this future plant’s strategy These initial commercial contracts …
Clinical asset management industry report highlights major trends reshaping health care in 2025
GlobeNewswire
·
May 27, 2025
Indianapolis, Indiana, May 27, 2025 (GLOBE NEWSWIRE) -- As health care enters a new era marked by technological innovation and regulatory challenges, TRIMEDX has released a 2025 industry report on clinical asset management, offering a deep dive into the …
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense
GlobeNewswire
·
May 27, 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS◊ TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* contract for up to $75 million by the U.S. Department of …
Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale
GlobeNewswire
·
May 27, 2025
Pittsburgh, PA, May 27, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we” or “our”), a company dedicated to advancing human longevity and healthy aging through regenerative bio-aesthetics, diagnostics, and …
INDYCAR Driver Conor Daly To Share His Personal Diabetes Story and Race Go-Karts With Detroit Area Youth On Thursday, May 29
GlobeNewswire
·
May 27, 2025
WESTLAKE VILLAGE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) will team up with NTT INDYCAR SERIES driver Conor Daly, who is living with Type 1 diabetes (T1D) for a one-of-a-kind experience with Detroit area youth and …